Skip to content

AngioDynamics ANGO Free cash flow margin

Discontinued — last reported Q1 '22

Free cash flow margin at other companies

Abbott logo
AbbottABT
16.3%+0.6pp
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
16.4%
TFX
TeleflexTFX
7.9%
Stryker logo
StrykerSYK
18.1%+2.7pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
14.3%+1.3pp
ICU Medical logo
ICU MedicalICUI
4.2%-1.2pp

Other financials

Income statement

See full
Revenue$78.4M+8.9%
Gross profit$41.5M+6.7%
Operating income-$13.0M-29.8%
Net income-$8.1M-83.4%
EPS (diluted)-$0.19-72.7%

Balance sheet

See full
Cash & equivalents$37.8M-15.5%
Total debt$7.9M+10.2%
Total equity$173.4M-6.7%
Total assets$260.7M-8.7%

Cash flow

See full
Operating cash flow-$3.1M+76.4%
CapEx$1.0M-43.5%
Free cash flow-$4.1M+72.4%

Valuation

See full
Market cap$564.42M+38.7%
Enterprise value$534.51M+48.0%
P/S1.8×+0.4×

Profitability

See full
Gross margin54.3%-0.1pp
Operating margin-11.3%-2.9pp
Net margin-10%-2.4pp

Returns & leverage

See full
Return on equity-17.5%-2.2pp
Debt / equity0.0×
Current ratio2.4×+0.1×

Where this comes from

Calculated from AngioDynamics’s reported figures.

Based on trailing twelve months.

The official record: AngioDynamics’s 10-Q, filed September 30, 2021, on SEC EDGAR. View the filing →

Ask your AI about AngioDynamics's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AngioDynamics's free cash flow margin?
AngioDynamics (ANGO) reported free cash flow margin of 5.5% in Q2 2021.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.